v3.26.1
DECONSOLIDATION OF SUBSIDIARIES
12 Months Ended
Dec. 31, 2024
Deconsolidation Of Subsidiaries  
DECONSOLIDATION OF SUBSIDIARIES

NOTE 20 – DECONSOLIDATION OF SUBSIDIARIES

 

Deconsolidation of Orgenesis Biotech Israel Limited (“OBI”)

 

On February 14, 2024, following a claim for payment by employees of OBI of past salaries due, the district court in Haifa, Israel appointed a trustee to run the affairs of OBI. As a result of this appointment, effective February 14, 2024, the Company no longer controlled OBI and has ceased to consolidate the results of OBI into its consolidated results. The Company recognized a loss as a result of the deconsolidation of $66. The Company does not currently believe that rehabilitation is possible and purchased certain OBI equipment.

 

The Company recorded $2,695 being what it owes to OBI under Accounts payable related Parties on the balance sheet of December 31, 2024.

 

The following table summarizes the deconsolidated assets and liabilities as of February 14, 2024:

 

      
Total assets acquired:     
Cash and cash equivalents  $4 
Property, plants and equipment, net   2,884 
Other Assets   1,422 
Total assets  $4,310 
      
Total liabilities:  $4,244 
Total Net Assets deconsolidated  $66 
Loss from deconsolidation of OBI  $66 

 

Deconsolidation of Korea, Belgium, Services

 

Deconsolidation of Orgenesis Korea

 

During 2024, following a claim for payment by employees of Orgenesis Korea of past salaries due, the court in Korea ordered the liquidation of Orgenesis Korea. As a result of thereof, effective October 1, 2024 , the Company no longer controlled Orgenesis Korea and has ceased to consolidate the results of Orgenesis Korea into its consolidated results. The Company recognized a profit as a result of the deconsolidation of $1,335.

 

 

      
Total assets acquired:     
Cash and cash equivalents  $1 
Property, plants and equipment, net   - 
Other Assets   40 
Total assets  $41 
      
Total liabilities:  $749 
Total Net liabilities deconsolidated  $708 
Total accumulated other comprehensive income deconsolidated  $627 
Profit from deconsolidation of Orgenesis Korea  $1,335 

 

 

Deconsolidation of Orgenesis Belgium SRL and Orgenesis Services SRL (“the Belgian subsidiaries”)

 

On December 20, 2024, the Liège Business Court in Belgium appointed provisional liquidators for the Belgian subsidiaries. The Belgian subsidiaries had, on November 8, 2024, petitioned the Liège Business Court to allow a judicial reorganization pursuant to Article XX.41 of the Belgian Code of Economic Law. The petition followed the inability of the Belgian subsidiaries to pay employee payroll expenses and accounts payable.

 

As a result of thereof, effective December 20, 2024, the Company no longer controlled the Belgian subsidiaries and has ceased to consolidate their results into its consolidated results. The Company recognized a profit as a result of the deconsolidation of $3,213.

 

 

      
Orgenesis Belgium SRL     
Total assets acquired:     
Cash and cash equivalents  $  
Property, plants and equipment, net   13 
Other Assets   91 
Total assets  $104 
      
Total liabilities assumed:  $2,453 
Total net liabilities deconsolidated  $2,349 
Total Accumulated Other Comprehensive income deconsolidated   82 
Profit from deconsolidation of Orgenesis Belgium SRL  $2,431 

 

      
Orgenesis Services SRL     
Total assets acquired:     
Cash and cash equivalents  $5 
Property, plants and equipment, net   768 
Other Assets   124 
Total assets  $897 
      
Total liabilities assumed:  $1,852 
Total net liabilities deconsolidated  $955 
Total Accumulated Other Comprehensive loss deconsolidated  $(175)
Profit from deconsolidation of Orgenesis Services SRL  $782 

 

The deconsolidation of the Belgian subsidiaries is described in this note. For related legal proceedings, including the appointment of provisional liquidators by the Liège Business Court, see note 22.